Point72 Asset Management
ALBO

Point72 Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Point72 Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,200
Closed -$523K – 2622
2022
Q4 		$523K Sell
24,200
-53,900
-69% -$1.14M ﹤0.01% 1143
2022
Q3 		$1.51M Buy
+78,100
New +$1.62M 0.01% 989
2022
Q2 		– Sell
-169,600
Closed -$5.06M – 1722
2022
Q1 		$5.06M Buy
169,600
+120,710
+247% +$3.53M 0.02% 703
2021
Q4 		$1.14M Buy
+48,890
New +$1.3M ﹤0.01% 893
2020
Q3 		– Sell
-175,000
Closed -$4.64M – 1149
2020
Q2 		$4.64M Sell
175,000
-340,000
-66% -$8.02M 0.03% 497
2020
Q1 		$8.43M Buy
515,000
+302,970
+143% +$6.66M 0.07% 324
2019
Q4 		$5.39M Buy
212,030
+124,124
+141% +$2.48M 0.03% 487
2019
Q3 		$1.76M Sell
87,906
-79,058
-47% -$2.05M 0.01% 614
2019
Q2 		$5.38M Sell
166,964
-16,531
-9% -$553K 0.03% 498
2019
Q1 		$5.91M Buy
183,495
+169,795
+1,239% +$4.57M 0.03% 525
2018
Q4 		$336K Buy
+13,700
New +$362K ﹤0.01% 887
2017
Q4 		– Sell
-186,640
Closed -$3.91M – 1145
2017
Q3 		$3.91M Buy
186,640
+171,098
+1,101% +$4.08M 0.02% 582
2017
Q2 		$320K Buy
+15,542
New +$319K ﹤0.01% 785

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 Asset Management's ALBO Position: Q1 2023 in Review

Point72 Asset Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 24,200 shares — an estimated $523K sold.

Point72 Asset Management first reported a position in ALBO in Q2 2017 and held it in 13 quarters. The position peaked at $8.43M in Q1 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Point72 Asset Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Point72 Asset Management sold 24,200 Albireo Pharma Inc shares in Q1 2023, an estimated $523K.
  • Point72 Asset Management first reported a position in Albireo Pharma Inc in Q2 2017 and held it in 13 quarters.
  • Point72 Asset Management's Albireo Pharma Inc position peaked at $8.43M in Q1 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Point72 Asset Management's 13F filing for Q1 2023, filed 15 May 2023.